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Coronary artery diseaseWe have excitedly read the paper of Palazhy et al.1 entitled
'Elevated oxidative stress among coronary artery disease
patients on statin therapy: a cross sectional study' published
in the May–June issue of Indian Heart J. 2015; 67(3): 227–32. They
investigated the oxidative stress and novel coronary artery
disease risk factors (e.g., apolipoprotein B, lipoprotein (a),
homocysteine) among coronary artery disease patients on
statins. They evaluated the oxidative stress by calculating
glutathione, glutathione peroxidase, superoxide dismutase,
ascorbic acid, malondialdehyde, and oxidized LDL. They also
compared apolipoprotein B, lipoprotein (a), homocysteine, and
lipid proﬁles between groups. Investigators allocated the
patients to three groups as following: Group 1, healthy controls
(n = 84); group 2, subjects with diabetes mellitus (DM) and
coronary artery disease on statin therapy (n = 151); and group
3, subjects with diabetes mellitus (n = 80). The patients in
Group 1 and Group 3 were not on statin therapy. Their analyses
revealed higher oxidative stress and lower antioxidant status
in Group 2 compared to those in both Group 1 and Group 3.
Therefore, they concluded that oxidative stress remained
higher in coronary artery patients, even though they were on
statin therapy. However, this interpretation does not make
sense because groups were different with regard to not only
presence of CAD but also hypertension and DM. However,
oxidative stress parameters and others might be affected by
not only statin therapy and coronary artery disease but alsodiabetes mellitus and hypertension. Some studies previously
reported an increased oxidative stress in hypertension.2,3
Another study showed that malondialdehyde signiﬁcantly
increased in hypertensive patients compared with normo-
tensive controls.4 On the other hand, as well as oxidative
stress parameters, novel atherosclerotic indicators might be
affected by hypertension. For example, Baszczuk et al.5
revealed that hypertensive patients with high homocysteine
tended to develop atherosclerosis. Taken together, the results
of this study are not sufﬁcient to say that coronary artery
disease itself, even under statin therapy, is associated with
higher oxidative stress. This uncertainty might be overcome
with the inclusion of coronary artery disease patients who
were under statin therapy but without DM and hypertension
into the study.
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